Subscribe today to HTA Quarterly - the e-newsletter with insights to bridge science and policy.

As a strategic consulting partner for hundreds of brands, we’ve learned what insights HEOR and Market Access teams find most useful. And we’ve designed an e-newsletter specifically with your needs in mind.

Take a look at what's in our current issue: 

  • Feature Story:
    Medical Nutritional Therapy: Achieving Reimbursement Across the Globe for Unique Non-drug Therapy Options
  • Therapeutic Spotlight:
    Biologic Treatments for Severe Asthma—a Paradigm Shift From Targeted to More Personalized Medicine
  • Emerging Market:
    Brazil—The Largest Market in Latin America

From at-a-glance updates on important HTA decisions, to reviews that shine a spotlight on what those decisions mean for specific therapeutic areas, each edition of the HTA Quarterly provides insight into the evolving perspectives and priorities for HTAs; as well as Xcenda’s unique perspective so you are more prepared to address the challenges of an uncertain and rapidly changing healthcare environment.